WHO Publishes Updated Essential Medicines, Diagnostics Lists

Forbes: WHO List of Essential Tests Gets An Upgrade
“Today, the World Health Organization (WHO) published two lists that are critical for global health: the 21st WHO Model List of Essential Medicines (EML), and the 2nd WHO Model List of Essential Diagnostics (EDL). The purpose of these lists is to help countries prioritize critical health products that should be widely available, accessible, and affordable throughout health systems, especially in low- and middle-income countries (LMICs)…” (Pai, 7/9).

Reuters: WHO updates its essential medicines list, adds cancer and stroke drugs
“…The [medicines] list included five new cancer therapies based on improved survival rates for lung, blood, and prostate cancers, and recommended two new immunotherapies — nivolumab and pembrolizumab — that had improved survival rates by 50% for advanced melanoma, which was incurable until recently…” (Miles, 7/9).